Evidence map›Paper›PMID 41271929›Full record

ArticleScientific reports2025

2-[

Patrícia Marques-Alves, Maria João Vidigal Ferreira, Rodolfo Silva, Andreia Gomes, Antero Abrunhosa, Miguel Castelo-Branco, Lino Gonçalves

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Patrícia Marques-AlvesCentro Académico e Clínico de Coimbra (Coimbra Hospital and University Center and Faculty of Medicine of University of Coimbra Consortium, Cardiology Department), Praceta Professor Mota Pinto, 3000-561, Coimbra, Portugal. pat.marques.alves@gmail.com.ORCID https://orcid.org/0000-0002-2639-4058
Maria João Vidigal FerreiraCentro Académico e Clínico de Coimbra (Coimbra Hospital and University Center and Faculty of Medicine of University of Coimbra Consortium, Cardiology Department), Praceta Professor Mota Pinto, 3000-561, Coimbra, Portugal.
Rodolfo SilvaCentro Académico e Clínico de Coimbra (Coimbra Hospital and University Center and Faculty of Medicine of University of Coimbra Consortium, Cardiology Department), Praceta Professor Mota Pinto, 3000-561, Coimbra, Portugal.
Andreia GomesCentro Académico e Clínico de Coimbra (Coimbra Hospital and University Center and Faculty of Medicine of University of Coimbra Consortium, Cardiology Department), Praceta Professor Mota Pinto, 3000-561, Coimbra, Portugal.
Antero AbrunhosaCoimbra Institute for Biomedical Imaging and Translational Research (CIBIT), Coimbra, Portugal.
Miguel Castelo-BrancoCentro Académico e Clínico de Coimbra (Coimbra Hospital and University Center and Faculty of Medicine of University of Coimbra Consortium, Cardiology Department), Praceta Professor Mota Pinto, 3000-561, Coimbra, Portugal.
Lino GonçalvesCentro Académico e Clínico de Coimbra (Coimbra Hospital and University Center and Faculty of Medicine of University of Coimbra Consortium, Cardiology Department), Praceta Professor Mota Pinto, 3000-561, Coimbra, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Risk stratification for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM) remains challenging. Enhanced imaging techniques could improve prognostic accuracy. This study investigates myocardial resting perfusion and metabolism using [

Indexed as

Cardiomyopathy, HypertrophicDeath, Sudden, CardiacFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyAdultAgedFemaleFibrosisHumansMaleMiddle AgedMyocardiumRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals2-[18F]FDG PET/CTHypertrophic cardiomyopathyMyocardial metabolismSudden cardiac death

Identifiers

PMID41271929
PMCPMC12639081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.